Researchers to conduct study on its efficacy on women under 25 years Kampala, Uganda | PATRICIA AKANKWATSA | Researchers of the vaccine programme at Uganda Virus Research Institute (UVRI) will start conducting a study among females below 25 years to assess the efficacy of Lenacapavir, an HIV injectable drug. Participants will …
Read More »